Status:
UNKNOWN
Risk Assessment Strategies in Pulmonary Embolism
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study is to evaluate different scores of risk assessment in patients with pulmonary embolism. This study aim to compare the accuracy of these scores in predicting mortality during hosp...
Detailed Description
Pulmonary embolism (PE) is a potentially life-threatening cardiovascular emergency with a high mortality rate.Approximately 1% of all hospitalized patients and 10% of all in-hospital mortalities are P...
Eligibility Criteria
Inclusion
- \-
- All patients will be subjected to the following:
- Complete history taking and clinical examination.
- Chest x-ray
- ECG and echocardiography.
- Arterial blood gases.
- Multislice CT angiography of the chest.
- Laboratory tests and biomarkers.
Exclusion
- 1- Patients with unexpected or accidental diagnosis of PE (patients undergoing diagnostic tests for another suspected disease.
- 2- Patients with acute left heart failure or acute respiratory failure responsible for symptoms.
- 3- Patient with recurrent PE (only the first event was included in the analysis).
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04327960
Start Date
September 1 2021
End Date
October 1 2023
Last Update
March 31 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.